Acalabrutinib +/- Obinutuzumab vs Obinutuzumab plus Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: ELEVATE-TN 4-Year Follow-up Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Pagel, J. M., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Corbett, G., Fogliatto, L., Herishanu, Y., Banerji, V., Coutre, S., Follows, G., Walker, P., Karlsson, K., Ghia, P., Janssens, A., Cymbalista, F., Woyach, J. A., Ferrant, E., Wierda, W. G., Munugalavadla, V., Patel, P., Wang, M., Byrd, J. C. CIG MEDIA GROUP, LP. 2021: S318-S319

View details for Web of Science ID 000691910500189